Stern Mariana C, Siegmund Kimberly D, Corral Román, Haile Robert W
Department of Preventive Medicine, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90089, USA
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):609-15. doi: 10.1158/1055-9965.EPI-04-0189.
Whereas animal and in vitro studies support a role of unsaturated fatty acids in colon carcinogenesis, the epidemiologic evidence is inconclusive. Using a large sigmoidoscopy-based case-control study (753 cases and 799 controls) in Los Angeles County, we investigated possible associations between single-nucleotide polymorphisms in the XRCC1 (codons 194 Arg/Trp and codon 399 Arg/Gln) and XRCC3 (codon 241 Thr/Met) genes and colorectal adenoma risk and their possible role as modifiers of the effect of monounsaturated fatty acid, the ratio of omega-6/omega-3 polyunsaturated fatty acids, and antioxidant intake. We found no evidence of associations between the XRCC1 codon 194 Arg/Trp or Trp/Trp genotypes and the XRCC3 codon 241 Thr/Met or Met/Met genotypes. Subjects with the XRCC1 Gln/Gln genotype were inversely associated with adenoma risk (odds ratio, 0.6; 95% confidence interval, 0.4-0.9; P = 0.01) when compared with subjects with Arg/Arg and Arg/Gln genotypes combined. We found no evidence of gene-dietary fat interactions for the XRCC3 codon 241 polymorphism. However, our data suggest an XRCC1-unsaturated fat interaction. High monounsaturated fatty acid intake was associated with adenoma risk only among subjects with the XRCC1 codon 194 Arg/Arg and codon 399 Gln/Gln combined genotypes (P for interaction = 0.018). High omega-6/omega-3 polyunsaturated fatty acid ratios were associated with adenoma risk among subjects with the XRCC1 codon 194 Arg/Arg and codon 399 Gln/Gln or the codon 194 Arg/Trp or Trp/Trp and codon 399 Arg/Arg or Arg/Gln combined genotypes (P for interaction = 0.026). These interactions were not modified by antioxidant intake. However, low antioxidant intake was associated with an inverse association only among subjects with the XRCC1 codon 194 Arg/Trp or Trp/Trp and codon 399 Arg/Arg or Arg/Gln combined genotypes (P for interaction = 0.022), which was independent of unsaturated fat intake. Our data suggest that the XRCC1 codon 194 and codon 399 single nucleotide polymorphisms may modify the effect of unsaturated fatty acid and antioxidant intake and that this XRCC1 effect modification may explain, in part, previously reported inconsistencies on the role of unsaturated fatty acids and adenoma risk.
虽然动物和体外研究支持不饱和脂肪酸在结肠癌发生中起作用,但流行病学证据尚无定论。我们在洛杉矶县开展了一项基于乙状结肠镜检查的大型病例对照研究(753例病例和799例对照),调查了XRCC1基因(密码子194 Arg/Trp和密码子399 Arg/Gln)和XRCC3基因(密码子241 Thr/Met)中的单核苷酸多态性与结直肠腺瘤风险之间的可能关联,以及它们作为单不饱和脂肪酸、ω-6/ω-3多不饱和脂肪酸比例和抗氧化剂摄入量效应修饰因子的可能作用。我们没有发现XRCC1密码子194 Arg/Trp或Trp/Trp基因型与XRCC3密码子241 Thr/Met或Met/Met基因型之间存在关联的证据。与Arg/Arg和Arg/Gln基因型组合的受试者相比,XRCC1 Gln/Gln基因型的受试者与腺瘤风险呈负相关(比值比,0.6;95%置信区间,0.4 - 0.9;P = 0.01)。我们没有发现XRCC3密码子241多态性存在基因 - 膳食脂肪相互作用的证据。然而,我们的数据表明存在XRCC1 - 不饱和脂肪相互作用。仅在XRCC1密码子194 Arg/Arg和密码子399 Gln/Gln组合基因型的受试者中,高单不饱和脂肪酸摄入量与腺瘤风险相关(交互作用P = 0.018)。在XRCC1密码子194 Arg/Arg和密码子399 Gln/Gln或密码子194 Arg/Trp或Trp/Trp和密码子399 Arg/Arg或Arg/Gln组合基因型的受试者中,高ω-6/ω-3多不饱和脂肪酸比例与腺瘤风险相关(交互作用P = 0.026)。这些相互作用不受抗氧化剂摄入量的影响。然而,仅在XRCC1密码子194 Arg/Trp或Trp/Trp和密码子399 Arg/Arg或Arg/Gln组合基因型的受试者中,低抗氧化剂摄入量与负相关有关(交互作用P = 0.022),这与不饱和脂肪摄入量无关。我们的数据表明,XRCC1密码子194和密码子399单核苷酸多态性可能会改变不饱和脂肪酸和抗氧化剂摄入量的效应,并且这种XRCC1效应修饰可能部分解释了先前报道的关于不饱和脂肪酸与腺瘤风险作用的不一致性。